🔎 Trials Near Me

Domov › Akutna mieločna levkemija › Arkansas › Little Rock

Klinične študije za Akutna mieločna levkemija v Little Rock, AR

13 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Little Rock in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Vključevanje udeležencevFaza 2
  • University of Arkansas for Medical Sciences, Little Rock
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • CARTI Cancer Center, Little Rock
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Arkansas for Medical Sciences, Little Rock
Starost 18–59 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • University of Arkansas at Little Rock, Little Rock
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Arkansas for Medical Sciences, Little Rock
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Arkansas for Medical Sciences, Little Rock
Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Arkansas for Medical Sciences, Little Rock
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3
  • Arkansas Children's Hospital, Little Rock
6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Vključevanje udeležencevFaza 3
  • Arkansas Children's Hospital, Little Rock
Starost 1–25 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2
  • Arkansas Children's Hospital, Little Rock
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • Arkansas Children's Hospital, Little Rock
29 Days – 21 Years · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Vključevanje udeležencevOpazovalna študija
  • Arkansas Children's Hospital, Little Rock
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Vključevanje udeležencevFaza 1
  • Arkansas Children's Hospital, Little Rock
Do 21 let · Vsi spoli · Posodobljeno 22. apr. 2026 · NCT05101551

Študije za Akutna mieločna levkemija v drugih mestih

Druge študije v Little Rock

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.